Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

T Cell Types and Functions01:24

T Cell Types and Functions

1.5K
When T cells with CD4 markers are activated, they give rise to two types of effector cells: helper T cells and regulatory T cells. Meanwhile, T cells with CD8 markers differentiate into effector cytotoxic T cells. The differentiation of CD4 T cells into helper T cell subsets, such as Th1, Th2, and Th17 cells, is dependent on the antigen type, antigen-presenting cell, and regulatory cytokines.
Th1 cells stimulate dendritic cells to express necessary co-stimulatory molecules on their surfaces for...
1.5K
NF-κB-dependent Signaling Pathway02:26

NF-κB-dependent Signaling Pathway

7.9K
The transcription factor NF-κB was discovered in 1986 in the lab of Nobel laureate Professor David Baltimore, for its interaction with the immunoglobulin light chain enhancer in B-cells. After more than three decades of study, it is now evident that NF-κB regulates the expression of over 100 genes. Most of these genes play an essential role in the innate and adaptive immune responses as well as the inflammatory responses of animals.
NF-κB-dependent Signaling Mechanism
The...
7.9K

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Sequential infection reprograms the immune landscape to shape future responses.

bioRxiv : the preprint server for biology·2026
Same author

Amyloid-related imaging abnormalities (ARIA) in Alzheimer's immunotherapy: a framework and challenges for global surveillance strategies.

Journal of neurology, neurosurgery, and psychiatry·2026
Same author

Elevated serum lipoprotein(a) as a prognostic marker for reduced survival in pancreatic cancer.

BMC gastroenterology·2025
Same author

ANKRD55 is a key regulator of T cell inflammation in multiple sclerosis.

The Journal of clinical investigation·2025
Same author

MXene-supported AgNPs in smart hydrogels: Shrink-enabled amplification for high-performance multi-channel SERS sensing.

Analytica chimica acta·2025
Same author

Advances in ε-Poly-Lysine Biosynthesis, Selection of High-Yielding Strains and Regulatory Mechanisms.

Biotechnology journal·2025

Related Experiment Video

Updated: Oct 13, 2025

Screening Bioactive Nanoparticles in Phagocytic Immune Cells for Inhibitors of Toll-like Receptor Signaling
09:51

Screening Bioactive Nanoparticles in Phagocytic Immune Cells for Inhibitors of Toll-like Receptor Signaling

Published on: July 26, 2017

12.5K

TLR Signaling in Brain Immunity.

Mengdi Guo1, Yun Xu1, Cun-Jin Zhang2

  • 1Department of Neurology of Nanjing Drum Tower Hospital, Medical School and the State Key Laboratory of Pharmaceutical Biotechnology, Nanjing University, Nanjing, China.

Handbook of Experimental Pharmacology
|November 11, 2021
PubMed
Summary

Toll-like receptors (TLRs) are key to immune responses and signal transduction. This review details TLR signaling in the central nervous system (CNS), highlighting its role in neurological disorders and therapeutic potential.

Keywords:
Central nervous systemImmune signaling pathwaysNeurological disordersToll-like receptor

More Related Videos

Isolation and Th17 Differentiation of Naïve CD4 T Lymphocytes
12:59

Isolation and Th17 Differentiation of Naïve CD4 T Lymphocytes

Published on: September 26, 2013

34.9K
Using RNA-interference to Investigate the Innate Immune Response in Mouse Macrophages
12:47

Using RNA-interference to Investigate the Innate Immune Response in Mouse Macrophages

Published on: November 3, 2014

11.8K

Related Experiment Videos

Last Updated: Oct 13, 2025

Screening Bioactive Nanoparticles in Phagocytic Immune Cells for Inhibitors of Toll-like Receptor Signaling
09:51

Screening Bioactive Nanoparticles in Phagocytic Immune Cells for Inhibitors of Toll-like Receptor Signaling

Published on: July 26, 2017

12.5K
Isolation and Th17 Differentiation of Naïve CD4 T Lymphocytes
12:59

Isolation and Th17 Differentiation of Naïve CD4 T Lymphocytes

Published on: September 26, 2013

34.9K
Using RNA-interference to Investigate the Innate Immune Response in Mouse Macrophages
12:47

Using RNA-interference to Investigate the Innate Immune Response in Mouse Macrophages

Published on: November 3, 2014

11.8K

Area of Science:

  • Immunology
  • Neuroscience

Background:

  • Toll-like receptors (TLRs) are transmembrane proteins vital for pathogen recognition and immune homeostasis.
  • Research over two decades has elucidated TLR structure and function in health and disease.

Purpose of the Study:

  • To review the current understanding of Toll-like receptor (TLR) signaling within the central nervous system (CNS).
  • To discuss the implications of TLR signaling in neurological disorders and potential therapeutic strategies.

Main Methods:

  • Literature review of existing research on TLRs and CNS immunity.

Main Results:

  • The CNS, once considered immune-privileged, is now recognized as immune-specialized with active TLR signaling.
  • TLR signaling plays a significant role in the pathological mechanisms of various neurological disorders.

Conclusions:

  • Understanding TLR signaling in the CNS is crucial for investigating neurological disease pathology.
  • Targeting TLR signaling presents a promising avenue for therapeutic interventions in neurological disorders.